Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $10,799 | 7 | 44.9% |
| Food and Beverage | $6,512 | 59 | 27.1% |
| Honoraria | $4,400 | 2 | 18.3% |
| Travel and Lodging | $2,323 | 4 | 9.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Ion Beam Applications S.A. | $6,821 | 5 | $0 (2024) |
| TOLMAR Pharmaceuticals, Inc. | $6,212 | 15 | $0 (2022) |
| Blue Earth Diagnostics Limited | $3,338 | 17 | $0 (2024) |
| GENZYME CORPORATION | $2,319 | 1 | $0 (2022) |
| Tolmar, Inc. | $1,875 | 3 | $0 (2024) |
| IBA Proton Therapy, Inc. | $1,357 | 4 | $0 (2024) |
| Medical Device Business Services, Inc. | $867.98 | 6 | $0 (2018) |
| PROGENICS PHARMACEUTICALS, INC. | $415.23 | 7 | $0 (2024) |
| BAXTER HEALTHCARE | $213.57 | 3 | $0 (2017) |
| PALETTE LIFE SCIENCES, INC. | $168.12 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,685 | 12 | Ion Beam Applications S.A. ($1,924) |
| 2023 | $1,059 | 14 | Progenics Pharmaceuticals, Inc. ($317.43) |
| 2022 | $6,224 | 9 | TOLMAR Pharmaceuticals, Inc. ($3,323) |
| 2021 | $364.56 | 7 | TOLMAR Pharmaceuticals, Inc. ($254.20) |
| 2020 | $2,600 | 1 | TOLMAR Pharmaceuticals, Inc. ($2,600) |
| 2019 | $1,519 | 2 | Ion Beam Applications S.A. ($1,500) |
| 2018 | $1,143 | 10 | Medical Device Business Services, Inc. ($867.98) |
| 2017 | $6,440 | 17 | Ion Beam Applications S.A. ($3,397) |
All Payment Transactions
72 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2024 | Tolmar, Inc. | — | Honoraria | Cash or cash equivalent | $1,800.00 | General |
| 10/16/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: Diagnostic Imaging | ||||||
| 09/30/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $43.71 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 09/19/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $151.02 | General |
| Category: Diagnostic Imaging | ||||||
| 09/13/2024 | Ion Beam Applications S.A. | — | Food and Beverage | Cash or cash equivalent | $1,924.44 | General |
| Category: PROTON THERAPY | ||||||
| 08/09/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $33.60 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 07/31/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 04/17/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $114.50 | General |
| Category: Diagnostic Imaging | ||||||
| 04/05/2024 | IBA Proton Therapy, Inc. | — | Food and Beverage | Cash or cash equivalent | $273.00 | General |
| Category: PROTON THERAPY | ||||||
| 04/05/2024 | IBA Proton Therapy, Inc. | — | Food and Beverage | Cash or cash equivalent | $273.00 | General |
| Category: PROTON THERAPY | ||||||
| 03/13/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 03/06/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: Diagnostic Imaging | ||||||
| 12/07/2023 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $23.88 | General |
| Category: Diagnostic Imaging | ||||||
| 11/09/2023 | icotec Medical Inc. | icotec BlackArmor Spine System (Device), icotec BlackArmor Spine System | Food and Beverage | In-kind items and services | $38.64 | General |
| Category: Spine stabilization for spine tumor patients | ||||||
| 11/08/2023 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $25.20 | General |
| Category: Diagnostic Imaging | ||||||
| 10/19/2023 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Diagnostic Imaging | ||||||
| 10/01/2023 | Progenics Pharmaceuticals, Inc. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $61.21 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 09/28/2023 | Progenics Pharmaceuticals, Inc. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 08/01/2023 | Progenics Pharmaceuticals, Inc. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $133.02 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 07/26/2023 | Blue Earth Diagnostics Limited | POSLUMA (Drug), Axumin | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Diagnostic Imaging | ||||||
| 06/28/2023 | IBA Proton Therapy, Inc. | — | Food and Beverage | Cash or cash equivalent | $251.28 | General |
| Category: PROTON THERAPY | ||||||
| 06/14/2023 | PALETTE LIFE SCIENCES, INC. | — | Food and Beverage | In-kind items and services | $168.12 | General |
| 06/14/2023 | Tolmar, Inc. | ELIGARD (Drug) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: Prostate Cancer | ||||||
| 05/16/2023 | Tolmar, Inc. | ELIGARD (Drug) | Food and Beverage | In-kind items and services | $56.91 | General |
| Category: Prostate Cancer | ||||||
| 05/04/2023 | Blue Earth Diagnostics Limited | Axumin (Drug) | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: Diagnostic Imaging | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 32 | 2,518 | 17,663 | $18.8M | $2.2M |
| 2022 | 36 | 2,702 | 18,881 | $21.4M | $2.7M |
| 2021 | 37 | 2,759 | 18,472 | $20.1M | $2.3M |
| 2020 | 38 | 2,430 | 17,125 | $26.7M | $3.0M |
All Medicare Procedures & Services
143 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77523 | Intermediate proton beam radiation treatment | Office | 2023 | 133 | 978 | $7.5M | $799,462 | 10.7% |
| 77525 | Complex proton beam radiation treatment | Office | 2023 | 85 | 682 | $5.2M | $625,880 | 12.0% |
| A9595 | Piflufolastat f-18, diagnostic, 1 millicurie | Office | 2023 | 43 | 267 | $498,456 | $173,231 | 34.8% |
| G6002 | Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy | Office | 2023 | 164 | 1,934 | $1.2M | $116,059 | 9.4% |
| 77301 | High precision radiation therapy planning | Office | 2023 | 61 | 62 | $398,722 | $91,488 | 22.9% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 76 | 582 | $2.1M | $78,083 | 3.7% |
| 77427 | Radiation treatment management, 5 treatment sessions | Office | 2023 | 65 | 439 | $468,413 | $66,566 | 14.2% |
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | Office | 2023 | 56 | 56 | $268,912 | $65,802 | 24.5% |
| 77336 | Continuing radiation therapy consultation per week | Office | 2023 | 64 | 438 | $150,234 | $30,248 | 20.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 295 | 310 | $77,500 | $18,192 | 23.5% |
| 77373 | Cranial lesion surgery using radiation over multiple sessions | Office | 2023 | 15 | 20 | $164,200 | $15,680 | 9.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 74 | 74 | $52,466 | $12,676 | 24.2% |
| 72197 | Mri scan of pelvis before and after contrast | Office | 2023 | 49 | 49 | $155,869 | $9,654 | 6.2% |
| 77300 | Calculation of radiation therapy dose | Office | 2023 | 59 | 171 | $62,415 | $9,032 | 14.5% |
| 77263 | Complex radiation therapy planning | Office | 2023 | 59 | 60 | $61,320 | $7,884 | 12.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 472 | 883 | $17,660 | $7,393 | 41.9% |
| 77470 | Special radiation treatment | Office | 2023 | 59 | 59 | $105,846 | $6,224 | 5.9% |
| 55876 | Placement of device in prostate for radiation therapy | Office | 2023 | 50 | 50 | $23,400 | $5,983 | 25.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 40 | 40 | $19,840 | $5,674 | 28.6% |
| A4648 | Tissue marker, implantable, any type, each | Office | 2023 | 49 | 49 | $22,148 | $5,433 | 24.5% |
| 70553 | Mri scan of brain before and after contrast | Office | 2023 | 23 | 27 | $83,295 | $4,636 | 5.6% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 77 | 118 | $17,110 | $3,087 | 18.0% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2023 | 15 | 16 | $17,072 | $2,812 | 16.5% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 49 | 49 | $31,017 | $2,284 | 7.4% |
| A9585 | Injection, gadobutrol, 0.1 ml | Office | 2023 | 79 | 7,475 | $14,950 | $1,935 | 12.9% |
About Dr. Andrew Lee, M.D
Dr. Andrew Lee, M.D is a Radiation Oncology healthcare provider based in Irving, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1487746129.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andrew Lee, M.D has received a total of $24,034 in payments from pharmaceutical and medical device companies, with $4,685 received in 2024. These payments were reported across 72 transactions from 20 companies. The most common payment nature is "Consulting Fee" ($10,799).
As a Medicare-enrolled provider, Lee has provided services to 10,409 Medicare beneficiaries, totaling 72,141 services with total Medicare billing of $10.1M. Data is available for 4 years (2020–2023), covering 143 distinct procedure/service records.
Practice Information
- Specialty Radiation Oncology
- Location Irving, TX
- Active Since 09/29/2006
- Last Updated 04/10/2017
- Taxonomy Code 2085R0001X
- Entity Type Individual
- NPI Number 1487746129
Products in Payments
- ELIGARD (Drug) $6,288
- Axumin (Drug) $2,850
- JEVTANA (Drug) $2,319
- HARMONIC Product Family (Device) $867.98
- POSLUMA (Drug) $488.04
- PYLARIFY (Drug) $415.23
- TISSEEL (Biological) $124.92
- Mepilex Border Post Op AG (Device) $93.72
- Surgical Care - Tisseel (Biological) $88.65
- MRIdian (Device) $86.66
- Perjeta (Biological) $64.43
- Invivo Clin Sols. (Device) $63.69
- icotec BlackArmor Spine System (Device) $38.64
- LUTONIX (Device) $37.74
- ILLUCCIX (Drug) $19.26
- EKOSONIC (Device) $15.62
- FLEXITOUCH (Device) $15.00
- Lupron (Drug) $10.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.